Prevalence of mental disorders in elderly people: the European MentDis_ICF65+ study

Sylke Andreas1, Holger Schulz2, Jana Volkert2

  • 1Sylke Andreas, PhD, Department of Medical Psychology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany and Institute of Psychology, Alpen-Adria Universität Klagenfurt, Klagenfurt, Austria; Holger Schulz, PhD, Jana Volkert, PhD, Maria Dehoust, PhD, Department of Medical Psychology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany; Susanne Sehner, MSc, Anna Suling, PhD, Department of Biometry and Epidemiology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany; Berta Ausín, PhD, School of Psychology, University Complutense of Madrid, Madrid, Spain; Alessandra Canuto, PhD, Division of Liaison Psychiatry and Crisis Intervention, Department of Psychiatry and Mental Health, University Hospitals of Geneva (HUG), Geneva, Switzerland; Mike Crawford, MD, Royal College of Psychiatrists, London, UK; Chiara Da Ronch, PhD, Luigi Grassi, MD, Section of Psychiatry, Department of Biomedical and Specialty Surgical Sciences, University of Ferrara, Ferrara, Italy; Yael Hershkovitz, MSc, Department of Psychiatry, Hadassah University Medical Center, Kiryat Hadassah, Jerusalem, Israel; Manuel Muñoz, PhD, School of Psychology, University Complutense of Madrid, Madrid, Spain; Alan Quirk, PhD, Royal College of Psychiatrists, London, UK; Ora Rotenstein, PhD, Department of Psychiatry, Hadassah University Medical Center, Kiryat Hadassah, Jerusalem, Israel; Ana Belén Santos-Olmo, MSc, School of Psychology, University Complutense of Madrid, Madrid, Spain; Arieh Shalev, MD, Department of Psychiatry, Hadassah University Medical Center, Kiryat Hadassah, Jerusalem, Israel; Jens Strehle, MSc, Institute of Clinical Psychology and Psychotherapy, Center of Clinical Epidemiology and Longitudinal Studies, Dresden, Germany; Kerstin Weber, PhD, Division of Liaison Psychiatry and Crisis Intervention, Department of Psychiatry and Mental Health, University Hospitals of Geneva (HUG), Geneva, Switzerland; Karl Wegscheider, PhD, Department of Biometry and Epidemiology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany; Hans-Ulrich Wittchen, PhD, Institute of Clinical Psychology and Psychotherapy, Center of Clinical Epidemiology and Longitudinal Studies, Dresden, Germany; Martin Härter, PhD, Department of Medical Psychology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany sandreas@uke.de.

Abstract

Related Concept Videos

Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
340
Diagnostic and Statistical Manual of Mental Disorders (DSM)01:27

Diagnostic and Statistical Manual of Mental Disorders (DSM)

The Diagnostic and Statistical Manual of Mental Disorders (DSM) serves as the primary classification system for mental health disorders, providing standardized diagnostic criteria for clinicians and researchers. First published by the American Psychiatric Association (APA) in 1952, the DSM has undergone several revisions to reflect evolving psychiatric understanding. The fifth edition, DSM-5, released in 2013, introduced key updates that expanded diagnostic categories and modified diagnostic...
1.5K
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
308
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
1.0K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
298
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
305